CEROW
CERO THERAPEUTICS HOLDINGS, INC.
Key Financials
Net Income
$-7732212
↓ 1251.3%
Operating Income
$-15300903
↓ 1605.5%
EPS (Diluted)
$-18.15
↑ 81.5%
Total Liabilities
$8.1M
↓ 43.4%
Total Assets
$6.2M
↓ 27.5%
Cash & Equivalents
$96873.00
↓ 79.6%
Shareholders' Equity
$-1894563.00
↑ 86.7%
Operating Cash Flow
$-1523604.00
↓ 39.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CEROW |
| Company Name | CERO THERAPEUTICS HOLDINGS, INC. |
| CIK | 1870404 |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 650-407-2376 |